When you begin therapy, PlexusDx providers help you establish a weekly schedule aligned with your work, family, and fitness commitments to maximize adherence
They are already approved for type-2 diabetes, weight loss, and heart disease
Community of Care : By becoming a member, you join a supportive community committed to achieving the best health outcomes together
They are a free, expert resource dedicated to helping you stay safe
A phase 3 trial of a higher-dose CagriSema formulation at 2.4/7.2 mg is planned for initiation in the second half of 2026, and the REDEFINE 11 trial, exploring CagriSemas full weight-loss potential, is expected to report data in the first half of 2027
Does semaglutide make you tired